Form 4 Filing for Malik Fady Ibraham - CYTOKINETICS INC

This filing details transactions made by Malik Fady Ibraham, EVP Research & Development at CYTOKINETICS INC. On April 21, 2026, Mr. Ibraham acquired 3,500 shares of Common Stock at a price of $7.80 per share, increasing his post-transaction holdings to 157,402 shares. Concurrently, he disposed of 3,500 shares of Common Stock at $65.69 per share, resulting in 153,902 shares remaining. Additionally, a derivative transaction involved the disposal of 3,500 shares through a Non-Qualified Stock Option, with a post-transaction balance of 54,886 shares. The exercise price for the option was $7.80, and it is set to expire on February 27, 2028. The filing was signed by John O. Faurescu as attorney-in-fact for Dr. Malik.